Fujiko Oh-hashi - Concepedia

Author

Fujiko Oh-hashi

Japanese Foundation For Cancer Research

Also Known As

F Oh-Hashi, F Oh-hashi, F. Oh-hashi, FUJIKO OH-HASHI, Fujiko Oh-Hashi, Fujiko Oh-hashi

Publications

454

Citations

H-Index

Concepts

All Affiliations

Japanese Foundation For Cancer Research

About

Fujiko Oh-hashi is an author at Japanese Foundation For Cancer Research specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	377
2	Cell Biology	6	6	312
3	Health Sciences	1	1	10
4	Allergy	1	1	32
5	Cellular Therapies	1	1	10

Fujiko Oh-hashi

Publications

390

Citations

H-Index

Page 1

	Year	Citations
Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Imad Naasani, Fujiko Oh-hashi, Tomoko Oh‐hara, PubMed Cancer-associated Enzyme TelomeraseMajor MechanismChemoprevention StrategyMajor Tea PolyphenolCancer Biology	2003	204
Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors. Tateshi Kataoka, Naomi Matsuura, Fujiko Oh-hashi, PubMed ImmunologyPathologyImmunologic MechanismBiological TherapyMouse Solid Tumors	1985	39
Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A. Tateshi Kataoka, Fujiko Oh-hashi, Shigeru Tsukagoshi, PubMed L1210 LeukemiaImmunologyImmunoeditingModified Leukemia CellsImmunotherapy	1977	32
Characteristics of in vitro antiproliferation activity of human interferon-? Tateshi Kataoka, Fujiko Oh-hashi, Yoshio Sakurai, Cancer Chemotherapy and Pharmacology Antiparasitic AgentPathogenesisImmunologyAntiviral ResponseHuman Interferon-	1982	21
Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432. Tateshi Kataoka, Fujiko Oh-hashi, Yoshio Sakurai Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) VaccinationMucosal VaccinationVaccine DevelopmentMedicineImmunology	1979	18
Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A. Tateshi Kataoka, Fujiko Oh-hashi, Yoshio Sakurai PubMed L1210 Murine LeukemiaImmunologyImmunologic MechanismImmune ResistanceImmunotherapy	1982	14
Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor. Tateshi Kataoka, Fujiko Oh-hashi, Shigeru Tsukagoshi, PubMed VaccinationMucosal VaccinationVaccine DevelopmentCombined AdministrationProtein-bound Polysaccharide	1977	14
Effect of combined use of anticancer drugs with a polysaccharide preparation, Krestin, on mouse leukemia P388. Fujiko Oh-hashi, Tateshi Kataoka, Shigeru Tsukagoshi Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)	1978	13
Enhancement of antiproliferation activity of vincristine and adriamycin by interferon. Tateshi Kataoka, Fujiko Oh-hashi, Yoshio Sakurai PubMed ImmunologyImmunoeditingImmunologic MechanismPharmacotherapyPharmaceutical Chemistry	1984	13
Relative contribution of antiproliferative and host immunity-associated activity of mouse interferon in murine tumor therapy. Tateshi Kataoka, Fujiko Oh-hashi, Yoshio Sakurai, PubMed Mouse InterferonVivo Therapeutic EffectChemoprevention StrategyImmunologyPathology	1984	12

Page 1